Addex Therapeutics Ltd Increase Through New Leases Liabilities Arising From Financing Activities
Addex Therapeutics Ltd (ADXN) reported Increase Through New Leases Liabilities Arising From Financing Activities of CHF 2.00 thousand for the 12-month period ending 2021-12-31, per its 20-F filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities · last filed 2023-03-30
| Period end | Increase Through New Leases Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2021-12-31 | 2.00K CHF 20-F · filed 2023-03-30 |
| 2020-12-31 | 27.61K CHF 20-F · filed 2022-03-10 |
| 2019-12-31 | 322.53K CHF 20-F · filed 2021-03-11 |